This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Duncan, S. H.
Right arrow Articles by Flint, H. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Duncan, S. H.
Right arrow Articles by Flint, H. J.
Agricola
Right arrow Articles by Duncan, S. H.
Right arrow Articles by Flint, H. J.

 Previous Article  |  Next Article 

Applied and Environmental Microbiology, October 2002, p. 5186-5190, Vol. 68, No. 10
0099-2240/02/$04.00+0     DOI: 10.1128/AEM.68.10.5186-5190.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Acetate Utilization and Butyryl Coenzyme A (CoA):Acetate-CoA Transferase in Butyrate-Producing Bacteria from the Human Large Intestine

Sylvia H. Duncan,* Adela Barcenilla, Colin S. Stewart, Susan E. Pryde, and Harry J. Flint

Division of Gut Microbiology and Immunology, Rowett Research Institute Bucksburn, Aberdeen AB21 9SB, United Kingdom

Received 15 February 2002/ Accepted 26 June 2002


arrow
ABSTRACT
 
Seven strains of Roseburia sp., Faecalibacterium prausnitzii, and Coprococcus sp. from the human gut that produce high levels of butyric acid in vitro were studied with respect to key butyrate pathway enzymes and fermentation patterns. Strains of Roseburia sp. and F. prausnitzii possessed butyryl coenzyme A (CoA):acetate-CoA transferase and acetate kinase activities, but butyrate kinase activity was not detectable either in growing or in stationary-phase cultures. Although unable to use acetate as a sole source of energy, these strains showed net utilization of acetate during growth on glucose. In contrast, Coprococcus sp. strain L2-50 is a net producer of acetate and possessed detectable butyrate kinase, acetate kinase, and butyryl-CoA:acetate-CoA transferase activities. These results demonstrate that different functionally distinct groups of butyrate-producing bacteria are present in the human large intestine.


arrow
INTRODUCTION
 
There is currently much interest in optimizing the health-protective activities of the colonic microflora and in preventing gastrointestinal disorders through control of the diet (4, 15, 16, 17). The anaerobic microbial communities of the gut are exceedingly complex, however, being characterized by high cell densities and strain diversity and a significant degree of interspecies cross-feeding and microbial interaction (9). Recent molecular studies have demonstrated that up to 75% of the 16S ribosomal DNA (rDNA) sequence diversity is apparently unrelated to known bacterial species (13, 25). The challenge now must be to identify and culture new bacterial species that contribute to key aspects of anaerobic metabolism in the gut.

The main products of microbial fermentation in the large intestine can vary significantly in their relative concentrations and production rates depending on diet and site of production (27, 28), with typical ratios in feces being around 3:1:1 acetate-propionate-butyrate (6, 7). Butyrate has a particularly important role as the preferred energy source for the colonic epithelium and a proposed role in providing protection against colon cancer and colitis (1, 4, 5). Butyrate can reduce gut mucosal inflammation by inhibiting the activity of the transcription factor NF-{kappa}B, which in turn mediates the effects of proinflammatory cytokines (14). Barcenilla et al. (2) recently isolated a range of butyrate-producing strains from human feces. Most (>80%) of the strains that produced high concentrations (>10 mM) of butyrate in batch culture in vitro have now been identified by 16S rDNA sequencing and phenotypic tests as species of the gram-positive anaerobes Roseburia (10) and Faecalibacterium (previously Fusobacterium) (11). Many of the Roseburia isolates (Table 1) were found to belong to a new species, Roseburia intestinalis (10). Nothing is currently known about the enzymology or physiology of butyrate production by any of these species.


View this table:
[in this window]
[in a new window]
  		TABLE 1. Effects of SCFA on growth rates of fecal bacteria on YCFAGSC medium

Butyrate is normally formed from two molecules of acetyl coenzyme A (CoA), yielding acetoacetyl-CoA, which is then converted to butyryl-CoA (reviewed in reference 8). Thereafter, butyryl-CoA may yield butyrate via butyrate kinase, as in some strains of ruminal Butyrivibrio fibrisolvens (8) or via butyryl-CoA:acetate-CoA transferase (Fig. 1). In the latter reaction butyryl-CoA is exchanged with exogenously derived acetate to yield acetyl-CoA and butyrate. Diez-Gonzalez et al. (8) suggested the existence of two distinct metabolic types, differing in acetate utilization and lactate formation, among butyrate-producing B. fibrisolvens strains from the rumen, apparently correlating with the possession of either butyrate kinase or butyryl-CoA:acetate-CoA transferase. Here we report metabolic and enzymological studies of strains belonging to four species of butyrate-producing bacteria from human feces, Coprococcus sp., Roseburia sp., R. intestinalis, and Faecalibacterium prausnitzii.



View larger version (15K):
[in this window]
[in a new window]
  		FIG. 1. Pathways for acetate and butyrate formation from glucose and glucose plus exogenous acetate. 1, butyryl-CoA:acetyl-CoA transferase; AcP, acetyl phosphate; But, butyryl or butyrate.


arrow
Butyrate-producing isolates.
 
The seven strains studied are human fecal isolates that were found to produce at least 10 mM butyrate in vitro on first isolation (2). Based on 16S rDNA sequences and phenotypic tests, strains L1-82, L1-952, and L1-8151 belong to the newly defined species R. intestinalis (10). Strains A2-181 and A2-183 appear to belong to another new species, not yet named, that is 95% related in rDNA sequence to Roseburia cecicola and will be referred to here as Roseburia sp. Strain L2-50 is a representative of Coprococcus sp. (2), and strain A2-165 belongs to the new genus Faecalibacterium (previously Fusobacterium) prausnitzii (11).


arrow
Growth requirements and media.
 
The strains studied here were originally isolated from anaerobic roll tubes with M2GSC (20) medium containing 30% clarified rumen fluid, as described by Barcenilla et al. (2). All seven strains were, however, able to grow in yeast extract-Casitone-fatty acids (YCFA) medium lacking rumen fluid provided that a mixture of sources of carbon and fatty acids (SCFA) (giving final concentrations of 33 mM acetate, 9 mM propionate, 1.2 mM iso-butyrate, 1.0 mM iso-valerate, and 1.0 mM valerate) was added (Table 1). Medium YCFAGSC contains the following ingredients (per 100 ml): 1 g of Casitone; 0.25 g of yeast extract; 0.2 g each of glucose, starch, and cellobiose; 0.4 g of NaHCO3; 0.1 g of cysteine; 0.045 g of K2HPO4; 0.045 g of KH2PO4; 0.09 g of NaCl; 0.009 g of MgSO4 · 7H2O; 0.009 g of CaCl2; 0.1 mg of resazurin; 1 mg of hemin; 1 µg of biotin; 1 µg of cobalamin; 3 µg of p-amino benzoic acid; 5 µg of folic acid; 15 µg of pyridoxamine; 5 µg of thiamine; and 5 µg of riboflavin. Thiamine and riboflavin were added to the medium as filter-sterilized solutions after being autoclaved (121°C, 15 min). Media were prepared and maintained under O2-free CO2 by the methods referred to in reference 2.

No growth occurred when fermentable carbohydrates were omitted from YCFAGSC medium (data not shown). Omitting all SCFA almost completely prevented the growth of Coprococcus sp. strain L2-50 and F. prausnitzii A2-165 and reduced the growth of Roseburia sp. strains A2-181 and A2-183 (Table 1). Addition of acetate as the sole SCFA restored or stimulated the growth of all strains except Coprococcus sp. strain L2-50. Strain L2-50 is therefore assumed to require one or more other SCFA for growth. F. prausnitzii A2-165 grows poorly on medium that does not contain acetate, and this requirement is likely to account for its previously observed dependence on rumen fluid (21).


arrow
Fermentation product analysis and fermentation balances.
 
Analysis of fermentation products demonstrated net utilization of acetate by the five Roseburia strains and by F. prausnitzii A2-165 when they were grown for 24 h in YCFAG medium (YCFAGSC medium without cellobiose or soluble starch but with glucose at 10 mM) (Table 2). All the strains produced butyrate, various amounts of formate, and relatively small amounts of lactate. The level of production of butyrate in these experiments was slightly lower, especially for Coprococcus sp. strain L2-50, than that previously reported for the same strains when they were grown on the rumen fluid containing M2GSC medium (2).


View this table:
[in this window]
[in a new window]
  		TABLE 2. Acidic fermentation products formed by butyrate-producing bacteria isolated from human feces on YCFAG[33] mediuma

In order to estimate carbon and electron recoveries, we performed additional experiments in which the medium was prepared and maintained under O2-free N2 in place of CO2 and NaHCO3 was omitted. In order to avoid possible contributions from energy sources other than glucose, Casitone was omitted and the concentration of yeast extract was reduced to 0.2% (wt/vol) (medium YFAG). F. prausnitzii A2-165, however, was found to require yeast extract and Casitone, and this strain was therefore grown on YCFAG. Carbon and electron recoveries were calculated with reference to appropriate control cultures lacking glucose. Acid production was determined by capillary gas chromatography (GC) following conversion to t-butyldimethylsilyl derivatives (22). H2 production was analyzed by packed-column GC (24). Carbon dioxide production was determined in these experiments by isotope dilution. Three replicate 24-h incubations were stopped by the addition of 1 ml of concentrated orthophosphoric acid through a gas-tight septum. One tube of each pair was used to determine the natural abundance of the CO2, and to the other tube 100 µl of 2.5 mM NaH13CO3 (98 atom%; Isotec Inc., Miamisburg, Ohio) was added by injection. All tubes were then shaken at 100°C for 15 min, and then 0.5 ml of the hot headspace gas was removed into a gas-tight syringe and injected into a continuous-flow gas isotope mass spectrometer (Tracermass 20-20; Europa Scientific, Crewe, Cheshire, United Kingdom). From the increase in enrichment (from ion intensities at m/z 44 and 45) above natural abundance and the amount of NaH13CO3 added, the total amount of CO2 in the tube was calculated. The amount of CO2 obtained in the uninoculated medium was subtracted to yield the quantity of CO2 produced. Theoretical CO2 values calculated according to the method discussed in reference 29 were in general higher than the measured values (Table 3).


View this table:
[in this window]
[in a new window]
  		TABLE 3. Recoveries of carbon and electrons for four butyrate-producing strains grown in batch culture

Carbon recoveries were determined using the theoretical CO2 values, as the direct measurements appear likely to be underestimated due to incomplete recovery of CO2 in the growth medium. On this basis, carbon recoveries ranged from 94 to 102% (Table 3). Strains were screened for ethanol and butanol production by GC, but no traces of these products were found. The electron balance for F. prausnitzii A2-165, which gave the lowest carbon recoveries and which did not produce H2, suggested that the products were comparatively oxidized (85.4%). Whether or not the fermentation by these bacteria was accompanied by changes in the redox balance of the (highly reduced) medium was not examined.


arrow
Strain distribution of key butyrate synthetic activities.
 
For the determination of butyrate pathway enzymes, strains were grown on M2GSC medium (80 ml) for 6 to 8 h (mid-exponential phase) and for 20 h (stationary phase) and the bacterial cell pellets were harvested by centrifugation (10,000 x g for 10 min) at 4°C. The cells were washed in 50 mM phosphate buffer containing 0.05% cysteine-HCl, centrifuged as described above, and resuspended in 4 ml of the same buffer. The cells were disrupted by sonication (MSE Soniprep setting 150 for 3 min). The disrupted cells were centrifuged at 10,000 x g for 5 min, and the cell debris was discarded; the extracts were used for determination of enzyme activities. Acetate kinase and butyrate kinase activities were determined by a colorimetric assay (23). Butyryl-CoA:acetate-CoA transferase activity was measured by the method of Barker et al. (3). The protein contents of the extracts were measured after boiling the extracts in alkali (18).

Significant butyrate kinase activity was detected in only one of the seven strains (Coprococcus sp. strain L2-50) (Table 4). Butyryl-CoA:acetate-CoA transferase activity, however, was detected in all seven strains in both the exponential and stationary phase, demonstrating that this is a potentially important route for butyrate synthesis among human fecal isolates. Coprococcus sp. strain L2-50 possessed the highest butyryl-CoA:acetate-CoA transferase activity in exponentially growing cells. Activities for this enzyme were 2.5- to 12-fold higher in exponential- than in stationary-phase cells in six of the seven strains, the exception being F. prausnitzii A2-165, for which activities were similar at the two growth stages.


View this table:
[in this window]
[in a new window]
  		TABLE 4. Enzymatic activities of butyrate-producing strains harvested in exponential and stationary phases


arrow
Conclusions.
 
The butyrate-producing strains studied here represent four distinct species of gram-positive anaerobes that belong to the Clostridium coccoides (Roseburia sp., Coprococcus sp.) and Clostridium leptum (F. prausnitzii) clusters of gram-positive bacteria. Bacteria belonging to these clusters are dominant members of the human intestinal flora, but they are frequently underrepresented among cultured isolates (12, 25, 29). F. prausnitzii may represent up to 15% of the human fecal microflora (26). Although first recovered using a complex rumen fluid-based medium (2), all four species can be grown on simpler rumen fluid-free media supplemented with short-chain fatty acids. F. prausnitzii shows a strong requirement for acetate, and Coprococcus sp. strain L2-50 apparently requires an SCFA other than acetate for growth. The difficulty in cultivating many human gut anaerobes may therefore often be overcome simply through supplying essential nutrients that are normally available by cross-feeding from other bacteria in the complex ecosystem in vivo.

Little work has been done previously on the enzymes that contribute to butyrate synthesis in commensal bacteria from the human colon. Butyrate kinase was detected here in only one strain, Coprococcus sp. strain L2-50. On the other hand, butyryl-CoA:acetate-CoA transferase activity was detected in all seven isolates studied here and thus provides the only known route for butyrate synthesis in the Roseburia sp. and F. prausnitzii strains.

These findings reveal a clear metabolic difference between the species studied. Roseburia sp. and F. prausnitzii strains show net acetate utilization and possess butyryl-CoA:acetate-CoA transferase but apparently lack butyrate kinase. On the other hand, Coprococcus sp. strain L2-50 produces acetate and possesses both butyrate kinase and butyryl-CoA transferase. At this stage we cannot say whether the net consumption or production of acetate is in general correlated with a lack of butyrate kinase activity. The behavior of these human fecal strains, however, recalls that of a subdivision noted by Diez-Gonzalez et al. (8) among rumen Butyrivibrio spp., although the two B. fibrisolvens strain groupings were reported to possess either butyrate kinase or butyryl-CoA:acetate-CoA transferase but not both activities. It is possible that additional patterns of butyrate metabolism exist among human fecal isolates, but this question must await a much wider strain survey. Interestingly, almost all (95%) of the strains isolated by Barcenilla et al. (2) that showed net acetate utilization proved to be butyrate producers, although only 50% of the butyrate producers showed net acetate consumption. This suggests a very strong link between acetate utilization and butyrate production in this group of human colonic bacteria. In strains of B. fibrisolvens that possess butyryl-CoA:acetate-CoA transferase, Diez-Gonzalez et al. (8) showed that increasing the acetate concentration favored butyrate production and shifted product ratios. It will be of interest to establish whether or not this effect occurs also in F. prausnitzii and Roseburia sp.

From the still-limited evidence available, it appears that F. prausnitzii, Roseburia sp., and related strains may account for a significant proportion of the more active butyrate-producing strains in the human colon (2, 13, 26). If so, we would predict that much of the butyrate carbon may be generated from acetate through the CoA transferase route in vivo, consistent with the findings of Miller and Wolin (19). It has also been suggested that utilization by butyrate producers of lactate produced by other species, such as bifidobacteria and lactobacilli, might be significant in vivo (15). None of the strains studied here were able to utilize lactate as a sole carbon and energy source, but we have not excluded the possibility that lactate can be utilized by strains growing on carbohydrates.

Given the current interest in dietary approaches for stimulating butyrate synthesis, especially in the distal large intestine, it is vital to understand the microbiology associated with butyrate synthesis and the relationships between substrate supply and product formation. Further work on metabolite flow in vivo and on the prevalence of Roseburia sp., Coprococcus sp., and F. prausnitzii strains, in particular, in different individuals and in response to diet appears desirable.


arrow
ACKNOWLEDGMENTS
 
We thank Kenneth Young for technical help.

RRI receives financial support from the Scottish Executive Environment and Rural Affairs Department (SEERAD).


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Rowett Research Institute, Greenburn Rd., Bucksburn, Aberdeen AB21 9SB, United Kingdom. Phone: 44 (0) 1224 712751. Fax: 44 (0) 1224 716687. E-mail: shd{at}rri.sari.ac.uk. Back


arrow
REFERENCES
 
    1
  1. Archer, S., S. Meng, J. Wu, J. Johnson, R. Tang, and R. Hodin. 1998. Butyrate inhibits colon carcinoma cell growth through two distinctive pathways. Surgery 124:248-253.[Medline]
    2. 2
  2. Barcenilla, A., S. E. Pryde, J. C. Martin, S. H. Duncan, C. S. Stewart, C. Henderson, and H. J. Flint. 2000. Phylogenetic relationships of butyrate-producing bacteria from the human gut. Appl. Environ. Microbiol. 66:1654-1661.[Abstract/Free Full Text]
    3. 3
  3. Barker, H. A., E. R. Stadtman, and A. Kornberg. 1955. Coenzyme A transferase from Clostridium kluyverii. Methods Enzymol. 1:599-600.[CrossRef]
    4. 4
  4. Christl, S. U., H.-D. Eisner, G. Dusel, H. Kasper, and W. Scheppach. 1996. Antagonistic effects of sulfide and butyrate on proliferation of colonic mucosa: a potential role for these agents in the pathogenesis of ulcerative colitis. Dig. Dis. Sci. 41:2477-2481.[CrossRef][Medline]
    5. 5
  5. Csordas, A. 1996. Butyrate, aspirin, and colorectal cancer. Eur. J. Cancer Prevent. 5:221-231.[CrossRef][Medline]
    6. 6
  6. Cummings, J. H. 1995. Short chain fatty acids, p. 101-130. In G. R. Gibson and G. T. MacFarlane (ed.), Human colonic bacteria. CRC Press, Ann Arbor, Mich.
    7. 7
  7. Cummings, J. H., E. W. Pomare, W. J. Branch, C. P. E. Naylor, and G. T. Macfarlane. 1987. Short chain fatty acids in the human large intestine, portal, hepatic and venous blood. Gut 28:1221-1227.[Abstract/Free Full Text]
    8. 8
  8. Diez-Gonzalez, F., D. R. Bond, E. Jennings, and J. B. Russell. 1999. Alternative schemes of butyrate production in Butyrivibrio fibrisolvens and their relationship to acetate utilization, lactate production, and phylogeny. Arch. Microbiol. 171:324-330.[CrossRef][Medline]
    9. 9
  9. Dolfing, J., and J. C. Gottschal. 1997. Microbe-microbe interactions, p. 373-433. In R. I Mackie, B. A. White, and R. E. Isaacson (ed.), Gastrointestinal microbiology, vol. 2. Chapman and Hall, New York, N.Y.
    10. 10
  10. Duncan, S. H., G. L. Hold, A. Barcenilla, C. S. Stewart, and H. J. Flint. 2002. Roseburia intestinalis sp. nov., a novel saccharolytic, butyrate-producing bacterium from human faeces. Int. J. Syst. Evol. Microbiol. 52:1615-1620.[Abstract]
    11. 11
  11. Duncan, S. H., G. L. Hold, H. J. M. Harmsen, C. S. Stewart, and H. J. Flint. Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium gen. nov., comb. nov. Int. J. Syst. Evol. Microbiol., in press.
    12. 12
  12. Franks, A. H., H. J. M. Harmsen, G. C. Rangs, G. J. Jaansen, and G. W. Welling. 1998. Variations of bacterial populations in human feces quantified by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl. Environ. Microbiol. 64:3336-3345.[Abstract/Free Full Text]
    13. 13
  13. Hold, G. L., S. E. Pryde, V. J. Russell, E. Furrie, and H. J. Flint. 2001. Assessment of microbial diversity in human colonic samples by 16S rDNA sequence analysis. FEMS Microbiol. Ecol. 39:33-39.
    14. 14
  14. Inan, M. S., R. J. Rasoulpour, L.Yin, A. K. Hubbard, D. W. Rosenberg, and C. Giardina. 2000. The luminal short-chain fatty acid butyrate modulates NF kappa B activity in a human colonic epithelial cell line. Gastroenterology 118:724-734.[CrossRef][Medline]
    15. 15
  15. Kanauchi, O., Y. Fujiyama, K. Mitsuyama, Y. Araki, T. Ishii, and T. Nakamura. 1999. Increased growth of Bifidobacteria and eubacteria by germinated barley foodstuff, accompanied by enhanced butyrate production in healthy volunteers. Int. J. Mol. Med. 3:175-179.[Medline]
    16. 16
  16. Kanauchi, O., T. Iwanaga, A. Andoh, Y. Araki, T. Nakamura, K. Mitsuyama, A. Suzuki, T. Hibi, and T. Bamba. 2001. Dietary fiber fraction of germinated barley foodstuff attenuated mucosal damage and diarrhea, and accelerated the repair of the colonic mucosa in an experimental colitis. J. Gastroenterol. Hepatol. 16:160-168.[CrossRef][Medline]
    17. 17
  17. Kritchensky, D. 1998. Cereal fibres and colorectal cancer: a search for mechanisms. Eur. J. Cancer Prevent. 7:533-539.
    18. 18
  18. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.[Free Full Text]
    19. 19
  19. Miller, T. L., and M. J. Wolin. 1996. Pathways of acetate, propionate, and butyrate formation by the human fecal microbial flora. Appl. Environ. Microbiol. 62:1589-1592.[Abstract]
    20. 20
  20. Miyazaki, K., J. C. Martin, R. Marinsek-Logar, and H. J. Flint. 1997. Degradation and utilization of xylans by the rumen anaerobe Prevotella bryantii (formerly P. ruminicola subsp. bovis) B14. Anaerobe 3:373-381.[CrossRef][Medline]
    21. 21
  21. Moore, W. E. C., L. V. Holdeman, and R. W. Kelly. 1984. Genus Fusobacterium Knorr, 1922 4AL, p. 631-637. In P. H. A. Sneath (ed.), Bergey's manual of systematic bacteriology, vol. 2. Williams and Wilkins, Baltimore, Md.
    22. 22
  22. Richardson, A. J., G. C. Calder, C. S. Stewart, and A. Smith. 1989. Simultaneous determination of volatile and non-volatile fermentation products of anaerobes by capillary gas chromatography. Lett. Appl. Microbiol. 9:5-8.
    23. 23
  23. Rose, I. A. 1955. Acetate kinase of bacteria. Methods Enzymol. 1:591-595.[CrossRef]
    24. 24
  24. Rumney, C., S. H. Duncan, C. Henderson, and C. S. Stewart. 1995. Isolation and characteristics of a wheatbran-degrading Butyrivibrio from human feces. Lett. Appl. Microbiol. 20:232-236.[Medline]
    25. 25
  25. Suau, A., R. Bonnet, M. Stutren, J.-J. Godon, G. R. Gibson, M. D. Collins, and J. Dore. 1999. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl. Environ. Microbiol. 65:4799-4807.[Abstract/Free Full Text]
    26. 26
  26. Suau, A., V. Rochet, A. Sghir, G. Gramet, M. Sutren, L. Rigottier, and J. Dore. 2001. Fusobacterium prausnitzii and related species represent a dominant group within the human fecal microflora. Syst. Appl. Microbiol. 24:139-145.[CrossRef][Medline]
    27. 27
  27. Titgemeyer, E. C., L. D. Bourquin, G. C. Fahey, Jr., and K. A. Garleb. 1991. Fermentability of various fiber sources by human faecal bacteria in vitro. Am. J. Clin. Nutr. 53:1418.[Abstract/Free Full Text]
    28. 28
  28. Weaver, G. A., J. A. Krause, T. L. Miller, and M. J. Wolin. 1992. Corn starch fermentation by the colonic microbial community yields more butyrate than does cabbage fiber fermentation: corn starch fermentation rates correlate negatively with methanogenesis. Am. J. Clin. Nutr. 55:70-77.[Abstract/Free Full Text]
    29. 29
  29. Wilson, K. H., and R. B. Blitchington. 1996. Human colonic biota studied by ribosomal DNA sequence analysis. Appl. Environ. Microbiol. 62:2273-2278.[Abstract]

Applied and Environmental Microbiology, October 2002, p. 5186-5190, Vol. 68, No. 10
0099-2240/02/$04.00+0     DOI: 10.1128/AEM.68.10.5186-5190.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Falony, G., Calmeyn, T., Leroy, F., De Vuyst, L. (2009). Coculture Fermentations of Bifidobacterium Species and Bacteroides thetaiotaomicron Reveal a Mechanistic Insight into the Prebiotic Effect of Inulin-Type Fructans. Appl. Environ. Microbiol. 75: 2312-2319 [Abstract] [Full Text]  
  • Duncan, S. H., Belenguer, A., Holtrop, G., Johnstone, A. M., Flint, H. J., Lobley, G. E. (2007). Reduced Dietary Intake of Carbohydrates by Obese Subjects Results in Decreased Concentrations of Butyrate and Butyrate-Producing Bacteria in Feces. Appl. Environ. Microbiol. 73: 1073-1078 [Abstract] [Full Text]  
  • Falony, G., Vlachou, A., Verbrugghe, K., Vuyst, L. D. (2006). Cross-Feeding between Bifidobacterium longum BB536 and Acetate-Converting, Butyrate-Producing Colon Bacteria during Growth on Oligofructose. Appl. Environ. Microbiol. 72: 7835-7841 [Abstract] [Full Text]  
  • Van der Meulen, R., Adriany, T., Verbrugghe, K., De Vuyst, L. (2006). Kinetic Analysis of Bifidobacterial Metabolism Reveals a Minor Role for Succinic Acid in the Regeneration of NAD+ through Its Growth-Associated Production. Appl. Environ. Microbiol. 72: 5204-5210 [Abstract] [Full Text]  
  • Belenguer, A., Duncan, S. H., Calder, A. G., Holtrop, G., Louis, P., Lobley, G. E., Flint, H. J. (2006). Two Routes of Metabolic Cross-Feeding between Bifidobacterium adolescentis and Butyrate-Producing Anaerobes from the Human Gut.. Appl. Environ. Microbiol. 72: 3593-3599 [Abstract] [Full Text]  
  • Manichanh, C, Rigottier-Gois, L, Bonnaud, E, Gloux, K, Pelletier, E, Frangeul, L, Nalin, R, Jarrin, C, Chardon, P, Marteau, P, Roca, J, Dore, J (2006). Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55: 205-211 [Abstract] [Full Text]  
  • Charrier, C., Duncan, G. J., Reid, M. D., Rucklidge, G. J., Henderson, D., Young, P., Russell, V. J., Aminov, R. I., Flint, H. J., Louis, P. (2006). A novel class of CoA-transferase involved in short-chain fatty acid metabolism in butyrate-producing human colonic bacteria. Microbiology 152: 179-185 [Abstract] [Full Text]  
  • Walker, A. W., Duncan, S. H., McWilliam Leitch, E. C., Child, M. W., Flint, H. J. (2005). pH and Peptide Supply Can Radically Alter Bacterial Populations and Short-Chain Fatty Acid Ratios within Microbial Communities from the Human Colon. Appl. Environ. Microbiol. 71: 3692-3700 [Abstract] [Full Text]  
  • Duncan, S. H., Louis, P., Flint, H. J. (2004). Lactate-Utilizing Bacteria, Isolated from Human Feces, That Produce Butyrate as a Major Fermentation Product. Appl. Environ. Microbiol. 70: 5810-5817 [Abstract] [Full Text]  
  • Louis, P., Duncan, S. H., McCrae, S. I., Millar, J., Jackson, M. S., Flint, H. J. (2004). Restricted Distribution of the Butyrate Kinase Pathway among Butyrate-Producing Bacteria from the Human Colon. J. Bacteriol. 186: 2099-2106 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Duncan, S. H.
Right arrow Articles by Flint, H. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Duncan, S. H.
Right arrow Articles by Flint, H. J.
Agricola
Right arrow Articles by Duncan, S. H.
Right arrow Articles by Flint, H. J.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»